Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

ClinicalTrials.gov ID: NCT01360632

Public ClinicalTrials.gov record NCT01360632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Two Fixed Doses of OPDC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Polaris Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo (an inactive substance) as add on treatment to an assigned FDA approved antidepressant treatment (ADT) in patients with Major Depressive Disorder who demonstrate an incomplete response to a prospective trial of the same assigned FDA approved ADT

Study identification

NCT ID
NCT01360632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,539 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Jul 31, 2013
Completion
Aug 31, 2013
Last update posted
Dec 31, 2015

2011 – 2013

United States locations

U.S. sites
52
U.S. states
26
U.S. cities
52
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Costa Mesa California
Research Site Glendale California
Research Site Orange California
Research Site San Diego California
Research Site Temecula California
Research Site Jacksonville Florida
Research Site Jacksonville Beach Florida
Research Site Miami Springs Florida
Research Site Tampa Florida
Research Site Winter Park Florida
Research Site Atlanta Georgia
Research Site Smyrna Georgia
Research Site Chicago Illinois
Research Site Oak Brook Illinois
Research Site Lafayette Indiana
Research Site Owensboro Kentucky
Research Site Baltimore Maryland
Research Site Haverhill Massachusetts
Research Site Weymouth Massachusetts
Research Site Rochester Hills Michigan
Research Site Creve Coeur Missouri
Research Site Las Vegas Nevada
Research Site Cherry Hill New Jersey
Research Site Toms River New Jersey
Research Site Brooklyn New York
Research Site Fresh Meadows New York
Research Site New York New York
Research Site Staten Island New York
Research Site Raleigh North Carolina
Research Site Beachwood Ohio
Research Site Cincinnati Ohio
Research Site Columbus Ohio
Research Site Oklahoma City Oklahoma
Research Site Portland Oregon
Not listed Salem Oregon
Research Site Norristown Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Lincoln Rhode Island
Research Site Columbia South Carolina
Research Site Memphis Tennessee
Research Site Austin Texas
Research Site Dallas Texas
Research Site Houston Texas
Research Site San Antonio Texas
Research Site Witchita Falls Texas
Research Site Charlottesville Virginia
Research Site Herndon Virginia
Research Site Bellevue Washington
Research Site Spokane Washington
Research Site Brown Deer Wisconsin
Research Site Middleton Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01360632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 31, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01360632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →